Cas:1003298-79-0 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine manufacturer & supplier

We serve Chemical Name:3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine CAS:1003298-79-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine

Chemical Name:3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine
CAS.NO:1003298-79-0
Synonyms:3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidin-6-ylamine;6-Amino-3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine;3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidin-6-amine
Molecular Formula:C5H3BrClN5
Molecular Weight:248.46800
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:80.48000
Exact Mass:246.92600
LogP:1.93220

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:


Contact us for information like 3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidin-6-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidin-6-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Amino-3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine Use and application,6-Amino-3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine technical grade,usp/ep/jp grade.


Related News: Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine manufacturer Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine supplier Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine vendor From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry. 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidin-6-amine factory Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion.